Anthony Bruno

Warner Chilcott Plc manufactures pharmaceutical products. It develops, markets, sells, and distributes prescription pharmaceutical products in the United States. Warner Chilcott was founded in 1992 and is headquartered in Larne, UK.

Warner Chilcott Ltd. develops and provides pharmaceutical products. It focuses on the women’s healthcare and dermatology segment. The company was founded in 1996 and headquartered in Hamilton, Bermuda.

Warner Chilcott Corp. manufactures pharmaceutical products. The firm develops markets and sells prescription pharmaceutical products. It offers its products in two therapeutic categories, women's healthcare and dermatology. The company is headquartered in Rockaway, NJ.

Warner Chilcott Holdings Co. III Ltd. discovers, develops, manufactures, and distributes pharmaceutical products. The company is headquartered in Rockaway, NJ

Warner-Lambert Co. used to manufacture and market pharmaceuticals, consumer health care products & confectionery. Its pharmaceutical products were ethical pharmaceuticals, biological products and hard-gelatin capsules. Its consumer health products were a wide range of products like oral care mouthwash/dental rinses, toothpaste, effervescent denture cleaning tablets, upper respiratory cold & sinus preparations, antihistamines, allergy products and cough syrups/suppressants. The company was headquartered in Morris Plains, NJ.

Warner Chilcott Plc is a pharmaceutical company which focuses on women's healthcare, gastroenterology, dermatology and urology segments of the North American. It develops the therapeutic products for the treatment of diseases related to the dermatology, musculoskeletal, women's healthcare and general healthcare and community. The company has manufacturing facilities are located in Puerto Rico, Northern Ireland and Germany. Warner Chilcott was founded in 1968 and is headquartered in Dublin, Ireland.

VYNE Pharmaceuticals Ltd. operates as a pharmaceutical company, which focuses on the development and commercialization of proprietary, innovative and differentiated topical drugs for dermatological therapy. Its product portfolios include minocycline foam, minocycline gel, mometasone foam, calcipotriene foam, triamcinolone acetonide foam, betamethasone valerate foam, and betamethasone dipropionate. The company was founded by Dov Tamarkin and Meir Eini on January 19, 2003 and is headquartered in Rehovot, Israel.

Menlo Therapeutics Inc. operates as biopharmaceutical company which is focused on the development and commercialization of serlopitant for the treatment of pruritus, or itch, associated with dermatologic conditions such as atopic dermatitis, psoriasis and prurigo nodularis. The company was founded by Ed F. Schnipper in October, 2011 and is headquartered in Bridgewater, CA.